This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Molecular Imaging Market

Market Insights on Molecular Imaging covering sales outlook, demand forecast & up-to-date key trends

Molecular Imaging Market by Modality (Positron Emission Tomography, Positron Emission Tomography- Computed Tomography, Positron Emission Tomography- Magnetic Resonance, Single Photon Emission Computed Tomography), Application, End User & Region - Forecast to 2021-2031

Molecular Imaging Market - About the Report

Molecular imaging is a diagnostic imaging technique that provides details of what is going on inside the body at the molecular and cellular level compared to other diagnostic imaging devices. It has great potential to impact medicine by detecting diseases in early stages, determining the severity of the disease, selecting personalized medicine, using specific therapies or targeted therapies, and evaluating specific cell-specific treatment effects.

Current clinical molecular imaging approaches primarily use Positron Emission Tomography (PET) or Single Photon Emission Computed Tomography (SPECT) -based techniques. Nuclear medicine provides diagnostics, prognostics, and predictive and intermediate endpoint biomarkers in oncology, cardiology, neurology, and infectious and inflammatory disorders. The molecular imaging market has grown exponentially over time, due to the growing need for the detection and monitoring of diseases such as cancer, neurology, and other rare genetic disorders.

With the increasing prevalence of cancer and other chronic diseases due to unhealthy lifestyles and often increasing geriatric population the need for efficient and accurate imaging systems will rise to find personalized treatment plans. Along with it the advancement in technologies such as PET/CT and SPECT is the principal growth driver of the molecular imaging market. Besides, the growing adoption of Molecular Imaging in emerging economies such as China, India, and others, will create new opportunities for the molecular imaging market.

Molecular imaging provides accuracy and precision, safety, speed, and ease-of-use in the diagnostic process. In its revised study, FMI offers insights into key factors driving demand across regions. This latest report tracks global sales of molecular imaging in 25 high-growth markets, where major traction is being witnessed in North America, followed by Europe. This edition (2021-2031) brings readers up-to-date with key developments in the market, providing analysis on how manufacturers and other stakeholders are reacting to change.

Customize this Report

Let us know your requirement to get
100% FREE customization

How the Historical and Future Outlook of Molecular Imaging Market Match Up?

Technological advances have increased the diversity of molecular imaging applications. Molecular imaging has evolved as a promising tool for early detection of cancers and cardiac diseases, providing a more complete picture of the tumour genome, as well as monitoring tumour emergence during disease. Molecular imaging provides the ability to accurately assess biological responses to the treatment of individual patients over time, opening the door to personalized medicine strategies guided by molecular imaging reporters.

Initiatives by governments for better regulatory measures and investments in research and development (R&D) and healthcare are expected to push demand. These investments are intended to aid the development of better and non-invasive techniques for early detection of cardiology or oncology-specific diseases. It is expected that in the years to come machine learning-based approaches for image classification will have a profound impact on the process and will lead to automation. Especially in paediatric oncology, minimal fluid biopsy attacks show a good way to identify the genomic features of a DNA tumour.

Increasing advancements in technology, product launches, mergers & acquisitions, and strategic collaborations by leading market players will lead to higher adoption of molecular imaging and will create opportunities for product developments. For instance, in 2019, Bruker Corporation launched a bench top magnetic resonance spectrometer with a high-field 9.4 Tesla small animal MRI system with integrated in-line PET.

According to FMI’s analysis, the molecular imaging market will expand at an impressive CAGR of around 11.3% from 2021 to 2031.

Molecular Imaging Market Download Report Brochure

How is Need for Better Accuracy and Precision in Diagnostic Imaging Affecting Demand?

Innovative techniques and products are constantly being developed within the healthcare sector to increase patient safety, which is an important factor driving growth. Molecular imaging gives scientists the ability to detect, visualize, and quantify cellular and molecular events in situ, creating a myriad of possibilities to advance the understanding of biological systems.

Cardiovascular diseases remain the leading cause of death in the West. Hence delivering more personalized and cost-effective treatment of atherosclerotic disease has been fuelling the demand for molecular imaging. It offers non-invasive and real-time visualization of biological processes in the living organism at a cellular and molecular level, providing practical information for the development of diagnostic, therapeutic, drug, and performance evaluation. Molecular imaging plays an important role in early detection of health concerns, accurate diagnosis, and drug development and discovery. In recent years, molecular imaging technology has seen some progress in the early detection, disease monitoring, drug development, gene therapy, and other fields

Advanced diagnostic devices with high precision and accuracy are gaining popularity in the oncology and cardiology segment. Along with that, regulatory bodies are continuously trying to create favourable scenarios for the development and commercialization of molecular imaging, owing to producing precise and non-invasive diagnostic imaging for cancers and other chronic diseases. The increasing geriatric population and unhealthy lifestyles have led to a rising incidence of chronic diseases, which is expected to significantly boost demand for molecular imaging. The rapid expansion of molecular imaging applications shows a promising prospect.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Why is PET-CT leading the Market?

There has been significant healthcare expenditure towards developing and improvising infrastructure in developing regions. About 90% of Positron Emission Tomography-Computed Tomography (PET-CT) procedures apply for cancer diagnostics and monitoring, but the imminent commercial release of novel radiotracers are intended to help diagnose common neurodegenerative conditions such as Alzheimer's disease. This has encouraged r acceptance of PET-CT in neurology.

PET-CT is increasingly utilized in cardiology for myocardial perfusion imaging. The increasing cancer population globally is propelling the PET-CT segment of molecular imaging technology. The demand for PET in radiation oncology is growing, and manufacturers are responding by introducing larger PET / CT scanners that are tailored to the specific needs of radiation therapy users. For example, Philips introduced a “Big Bore” version of its Gemini TF PET/CT that features an 85cm-diameter bore, which can accommodate radiotherapy positioning devices.

Clinical innovations, financial incentives, and improved healthcare infrastructure will increase the growth of genetic diagnostic labs for molecular imaging with precise and non-invasive methods of diagnostic assays.

What are the Key Challenges Faced by Manufacturers?

The lack of skilled professionals required to operate instruments is a major factor that can restrain the growth of the market for molecular imaging. Molecular imaging is a sensitive technique, and negligence in operation or lack of skill can ruin the process. Such techniques require highly qualified and trained professionals who understand the technology and mechanism.

Another restraint is product recalls. Adverse events associated with the use of molecular imaging devices in evaluation, diagnosis, staging, restaging, and follow-up on lesions, diseases, and organ dysfunctions, such as cancer, cardiovascular disease, and brain dysfunction may restrict the manufacturers.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Insights

Why is the U.S. Considered a Leading Market for Molecular Imaging?

Future Market Insights (FMI) has projected the U.S. to remain the most lucrative market throughout the forecast period. One of the key factors supporting market expansion is the presence of advanced healthcare infrastructure in the U.S., making it a lucrative market for molecular imaging.

According to the American Cancer Society, prostate, lung and bronchus, and colorectal cancers account for 42% of all cases in men. Whereas, breast, lung, and colorectal cancers account for 30% of all cancers in women. As per the National Cancer Institute, cancer incidence is 442.4 per 100,000 men and women per year, with a mortality rate of 158.3 per 100,000. This high rate of cancer in the U.S. is complementing demand, and the market is expected to expand at a significant CAGR of over 9% during the forecast period.

What is the Market Scope in Germany for Molecular Imaging?

Germany is one of the largest countries in Europe exhibiting a cancer incidence of 313.1 per 100,000 people. The most common cancers in Germany are breast, prostate, colorectal, lung, and bladder. These five types accounted for about 57% of all new cancer cases in Germany in 2012. In Germany, it is estimated that 51% of men and 43% of women will develop cancer during their lifetime.

The federal health department launched the German National Cancer Plan, the Nationaler Krebsplan, in 2008 and a partnership was established with the German Cancer Society (Deutsche Krebsgesellschaft), German Cancer Aid (Deutsche Krebshilfe), and the Association of German Inflammatory Centres. The program includes four broad areas of assessment; improving oncological care facilities and quality assurance; to ensure that cancer treatment is effective, and developing a more patient-centered approach. The Krebsfrüherkennungs- und -registergesetz (KFRG), which came into effect in April 2013, and proved to be a milestone in the implementation of this program, which stated the law of early detection of cancer.

The stage in which a person is diagnosed has a significant impact on the challenges they face after a phase of intensive treatment. Thus, molecular imaging supports this plan of the organization to offer early and precise diagnosis of cancer for its prompt treatment, thereby increasing the survival rate of cancer patients.

According to International Agency for Research on Cancer, cancer cases are expected to increase by 12% by 2030, making the leading cause of death in Europe. These factors are supporting expansion in Germany.

Why is France Considered a Lucrative Market for Molecular Imaging?

France has been witnessing surging cases of cancer. Prostate, breast, lung, and colorectal cancer account for more than 47% of all cases. Besides this, according to the World Health Organization (WHO), the prevalence rate of strokes in France is 1445 per 100,000 of population. Also according to DALY’s 2016 report, the prevalence of neurological disorders has been 2349 per 100,000 population.

Public health policies are actively involved in aiding cancer prevention and detection plans in France. The French National Cancer Institute is a health and science agency dedicated to cancer. The Institute covers the whole spectrum of the fight against cancer, with plans to detect cancer at the initial stage, to plan better and sustainable treatment for patients.

Why is Demand for Molecular Imaging Increasing in China?

There has been a significant rise in the number of domestic manufacturers and distributors in past few years in China. According to a report on cancer statistics in China and GLOBCAN, there were 4.3 million new cancer cases and 2.9 million deaths in China in 2018. China has a higher mortality rate due to cancer as compared to countries such as the U.S. and the U.K. Rising geriatric population and chronic diseases in China are expected to boost the demand for advanced technologies for disease diagnosis, creating opportunities for molecular imaging devices manufacturing.

How is India Faring in the Molecular Imaging Market?

The Indian Council of Medical Research (ICMR) has predicted that by the year 2020, India will see more than 1.7 million new cancer cases, and more than 880,000 Indians will die as a result. Unfortunately, most patients come to know about their cancer at an advanced stage of the disease. According to the neurological society of India, the prevalence rate of neurological disorders in India has been 2394 per 100000 population in 2014. According to which approximately 30 million people suffer from neurological disorders in India. The need of the hour is to have better and efficient detection techniques. Late detection is mainly due to a shortage of diagnostic centres at primary levels.

Among women, breast cancer is rising, with more than 21% among all cancer cases. While among males, mouth and lung cancer are the highest with 18.3% of all cancers. India is witnessing a high rate of cancer-related mortality due to the unavailability of precise diagnosis, and as such, lack of precise treatment. This means that there is huge scope for molecular imaging manufacturers in the country.

Molecular Imaging Market - Category-wise Insights

Why is PET-CT Highly Sought-after?

PET-CT is projected to account for approximately 34.3% of the global share among modality types through the forecast period. This is due to the high sensitivity and limitless depth of penetration, and quantitative capabilities PET-CT has become a powerful tool for clinical diagnosis and basic research including neurology, cardiology, and particularly oncology. In the clinic, PET is crucial for cancer detection and staging, as well as evaluation of response to therapy.  It is reported that whole-body PET/CT improves the accuracy of cancer diagnosis and staging.

Why Does the Oncology Segment Hold Leading Share among Applications?

Cancer ranks as a leading cause of death and a key barrier to increasing life expectancy in every country of the world. According to estimates from the World Health Organization in 2019, cancer is one of the leading causes of death before the age of 70 years in 112 of 183 countries and ranks third or fourth in a further 23 countries. Revenue from oncology is expected to increase at a CAGR of more than 11% over the forecasted period. The increasing cancer population globally will lead to the growth of the molecular imaging market for efficient diagnosis and treatment, during the forecast period.

Why are Hospitals Considered Leading End Users of Molecular Imaging?

Hospitals hold the largest market share and are expected to increase at a CAGR of more than 12% during the forecasted period. Growing geriatric population and cancer-related mortality will allow increased use of molecular imaging in hospital set-ups. This will in turn fuel the demand diagnostic imaging equipment as hospitals adopt measures to accommodate increasing footfall of patients.

Molecular Imaging Market - Competitive Landscape

Leading market players are focusing on expanding their product portfolios and global footprint, along with attracting investments through mergers, acquisitions, and strategic collaborations. For instance, In September 2020, Bruker Corporation announced the acquisition of Canopy Biosciences, LLC. This acquisition enhances Bruker’s offering in targeted multi-omics and fluorescence-based imaging techniques.

Some of the leading companies operating in the market are: 

  • Hermes Medical Solutions
  • Bruker Corporation
  • GE Company
  • Fujifilm Holdings Corp.
  • Siemens AG
  • Koninklijke Philips N.V.
  • Toshiba Medical System Corp.

*Full competitive intelligence with SWOT analysis available in the report. 

Scope of Report

Attribute

Details

Molecular Imaging Market Forecast Period

2021-2031

Molecular Imaging Market Historical Data Available for

2016-2020

Molecular Imaging Market Analysis

USD Million for Value and Volume in Units

Molecular Imaging Market - Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA

Molecular Imaging Market - Key Countries Covered

U.S., Canada, Brazil, U.K., Mexico, Germany, France, Italy, Spain,  BENELUX, Russia, Japan, India, China, Japan, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC, and South Africa

Molecular Imaging Market - Key Segments Covered

Modality, Application, End User, Region

Molecular Imaging Market - Key Companies Profiled

  • Hermes Medical Solutions
  • Bruker Corporation
  • GE Company
  • Fujifilm Holdings Corp.
  • Koninklijke Philips N.V.
  • Siemens AG
  • Toshiba Medical System Corp.
  • Mirada Medical Limited
  • Carestream Health, Inc.
  • Esaote SpA
  • Positron Corporation
  • Medisco Ltd.
  • Hitachi Medical Corp.
  • MIM Software Inc.

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Molecular Imaging Market by Category

Modality

  • Positron Emission Tomography (PET)
  • Positron Emission Tomography- Computed Tomography (PET-CT)
  • Positron Emission Tomography- Magnetic Resonance (PET-MR)
  • Single Photon Emission Computed Tomography (SPECT)
  • Software
    • On Premises Solutions
    • Cloud Based Solutions
  • Magnetic Resonance
  • Molecular Ultrasound Imaging

Application

  • Cardiology
  • Oncology
  • Gastrointestinal Disorders
  • Neurology Disorders
  • Others

 End User

  • Hospitals
    • 500+ Beds
    • 200-499 Beds
    • Less than 200 Beds
  • Ambulatory Surgical Centres
  • Diagnostic Centres

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA

Frequently Asked Questions

North America has the highest market share in the global molecular imaging market. Increasing pool of cancer patient along with a large number of R&D centres is creating high growth opportunities within the region. The U.S. currently leads the global market.

PET-CT is expected to be the most lucrative among the modality, with increasing demand for highly sensitive and high-precision diagnostic techniques. The segment is expected to continue to expand at a CAGR of more than 16% over the forecast period.

Some of the leading companies in this landscape are Bruker Corporation, GE Company, Fujifilm Holdings Corp., Koninklijke Philips N.V., Siemens AG, and Toshiba Medical System Corp.

Oncology is expected to dominate the market over the forecast period, generating revenue of 4703.8 Mn by 2031. On the other hand, research will experience significant growth at a CAGR of approximately 11.2% through 2031.

Hospitals are expected to dominate the market as leading end users between 2021 and 2031.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusion

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Product Adoption / Usage Analysis

    4.2. Strategic promotional strategies

5. COVID19 Crisis Analysis

    5.1. Current COVID19 Statistics and Probable Future Impact

    5.2. Current GDP Projection and Probable Impact

    5.3. Current Economic Projection as compared to 2008 financial analysis

    5.4. COVID19 and Impact Analysis, by Country

    5.5. 2020 Market Scenario

    5.6. Recovery Scenario – Short term, Midterm and Long Term Impact

6. Global Molecular Imaging Market Volume (‘000’ Units)  Analysis 2016-2020 and Forecast, 2021-2031

    6.1. Historical Market Volume (‘000’ Units)  Analysis, 2016-2020

    6.2. Current and Future Market Volume (‘000’ Units)  Projections, 2021-2031

        6.2.1. Y-o-Y Growth Trend Analysis

7. Global Molecular Imaging Market - Pricing Analysis, 2021-2031

    7.1. Regional Pricing Analysis By Modality

    7.2. Pricing Break-up

        7.2.1. Manufacturer Level Pricing

        7.2.2. Distributor Level Pricing

    7.3. Global Average Pricing Analysis Benchmark

8. Global Molecular Imaging Market Demand (in Value or Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031

    8.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    8.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Market Background

    9.1. Macro-Economic Factors

        9.1.1. Global GDP Growth Outlook

        9.1.2. Global Healthcare Expenditure Outlook

        9.1.3. Income Per Capita Outlook

    9.2. Forecast Factors - Relevance & Impact

        9.2.1. Investment in medical infrastructure development

        9.2.2. Emergence of alternative molecular imaging devices

        9.2.3. Growth in commercial diagnostics application

        9.2.4. Government support medical device research and development

        9.2.5. Changing lifestyles

        9.2.6. Epidemiology of cancer and other chronic diseases

    9.3. Market Dynamics

        9.3.1. Drivers

        9.3.2. Restraints

        9.3.3. Opportunity Analysis

10. Global Molecular Imaging Market Analysis 2016-2020 and Forecast, 2021-2031, by Modality 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Modality, 2016 - 2020

    10.3. Current and Future Market Size (US$ Mn)  and Volume Units Analysis and Forecast By Modality, 2021 - 2031

        10.3.1. Positron Emission Tomography (PET)

        10.3.2. Positron Emission Tomography- Computed Tomography (PET-CT)

        10.3.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

        10.3.4. Single Photon Emission Computed Tomography (SPECT)

        10.3.5. Software

            10.3.5.1. On Premises Solutions

            10.3.5.2. Cloud Based Solutions 

        10.3.6. Magnetic Resonance 

        10.3.7. Molecular Ultrasound Imaging

    10.4. Market Attractiveness Analysis By Modality 

11. Global Molecular Imaging Market Analysis 2016-2020 and Forecast, 2021-2031, by Application

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Application, 2016 - 2020

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2021-2031

        11.3.1. Cardiology

        11.3.2. Oncology

        11.3.3. Gastrointestinal Disorders

        11.3.4. Neurology Disorders

        11.3.5. Others 

    11.4. Market Attractiveness Analysis By Application

12. Global Molecular Imaging Market Analysis 2016-2020 and Forecast, 2021-2031, by End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By End User, 2016 - 2020

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2021-2031

        12.3.1. Hospitals

            12.3.1.1. 500+ Beds

            12.3.1.2. 200-499 Beds

            12.3.1.3. Less than 200 Beds

        12.3.2. Ambulatory Surgical Centres

        12.3.3. Diagnostic Centres

    12.4. Market Attractiveness Analysis By End User

13. Global Molecular Imaging Market Analysis 2016-2020 and Forecast, 2021-2031, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Region, 2016 - 2020

    13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. MEA

    13.4. Market Attractiveness Analysis By Region

14. North America Molecular Imaging Market Analysis 2016-2020 and Forecast 2021-2031

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        14.3.1. By Country

            14.3.1.1. U.S.

            14.3.1.2. Canada

        14.3.2. By Modality

        14.3.3. By Application

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Latin America Molecular Imaging Market Analysis 2016-2020 and Forecast 2021-2031

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        15.3.1. By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Argentina

            15.3.1.4. Rest of Latin America

        15.3.2. By Modality

        15.3.3. By Application

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Europe Molecular Imaging Market Analysis 2016-2020 and Forecast 2021-2031

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        16.3.1. By Country

            16.3.1.1. Germany

            16.3.1.2. Italy

            16.3.1.3. France

            16.3.1.4. U.K.

            16.3.1.5. Spain

            16.3.1.6. Russia

            16.3.1.7. Rest of Europe

        16.3.2. By Modality

        16.3.3. By Application

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. South Asia Molecular Imaging Market Analysis 2016-2020 and Forecast 2021-2031

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        17.3.1. By Country

            17.3.1.1. India

            17.3.1.2. Thailand

            17.3.1.3. Indonesia

            17.3.1.4. Malaysia

            17.3.1.5. Rest of South Asia

        17.3.2. By Modality

        17.3.3. By Application

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. East Asia Molecular Imaging Market Analysis 2016-2020 and Forecast 2021-2031

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020

    18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        18.3.1. By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

            18.3.1.4. Rest of East Asia

        18.3.2. By Modality

        18.3.3. By Application

        18.3.4. By End User

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Oceania Molecular Imaging Market Analysis 2016-2020 and Forecast 2021-2031

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020

    19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        19.3.1. By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Modality

        19.3.3. By Application

        19.3.4. By End User

    19.4. Market Attractiveness Analysis

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Molecular Imaging Market Analysis 2016-2020 and Forecast 2021-2031

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020

    20.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        20.3.1. By Country

            20.3.1.1. GCC Countries

            20.3.1.2. Turkey

            20.3.1.3. South Africa

            20.3.1.4. Rest of Middle East and Africa

        20.3.2. By Modality

        20.3.3. By Application

        20.3.4. By End User

    20.4. Market Attractiveness Analysis

    20.5. Key Market Participants - Intensity Mapping

    20.6. Drivers and Restraints - Impact Analysis

21. Key and Emerging Countries Molecular Imaging Market Analysis 2016-2020 and Forecast 2021-2031

    21.1. Introduction

        21.1.1. Market Value Proportion Analysis, By Key Countries

        21.1.2. Global Vs. Country Growth Comparison

    21.2. U.S. Molecular Imaging Market Analysis

        21.2.1. By Modality

        21.2.2. By Application

        21.2.3. By End User

    21.3. Canada Molecular Imaging Market Analysis

        21.3.1. By Modality

        21.3.2. By Application

        21.3.3. By End User

    21.4. Mexico Molecular Imaging Market Analysis

        21.4.1. By Modality

        21.4.2. By Application

        21.4.3. By End User

    21.5. Brazil Molecular Imaging Market Analysis

        21.5.1. By Modality

        21.5.2. By Application

        21.5.3. By End User

    21.6. U.K. Molecular Imaging Market Analysis

        21.6.1. By Modality

        21.6.2. By Application

        21.6.3. By End User

    21.7. Germany Molecular Imaging Market Analysis

        21.7.1. By Modality

        21.7.2. By Application

        21.7.3. By End User

    21.8. France Molecular Imaging Market Analysis

        21.8.1. By Modality

        21.8.2. By Application

        21.8.3. By End User

    21.9. Italy Molecular Imaging Market Analysis

        21.9.1. By Modality

        21.9.2. By Application

        21.9.3. By End User

    21.10. Spain Molecular Imaging Market Analysis

        21.10.1. By Modality

        21.10.2. By Application

        21.10.3. By End User

    21.11. BENELUX Molecular Imaging Market Analysis

        21.11.1. By Modality

        21.11.2. By Application

        21.11.3. By End User

    21.12. Russia Molecular Imaging Market Analysis

        21.12.1. By Modality

        21.12.2. By Application

        21.12.3. By End User

    21.13. Poland Molecular Imaging Market Analysis

        21.13.1. By Modality

        21.13.2. By Application

        21.13.3. By End User

    21.14. China Molecular Imaging Market Analysis

        21.14.1. By Modality

        21.14.2. By Application

        21.14.3. By End User

    21.15. Japan Molecular Imaging Market Analysis

        21.15.1. By Modality

        21.15.2. By Application

        21.15.3. By End User

    21.16. South Korea Molecular Imaging Market Analysis

        21.16.1. By Modality

        21.16.2. By Application

        21.16.3. By End User

    21.17. India Molecular Imaging Market Analysis

        21.17.1. By Modality

        21.17.2. By Application

        21.17.3. By End User

    21.18. ASEAN Molecular Imaging Market Analysis

        21.18.1. By Modality

        21.18.2. By Application

        21.18.3. By End User

    21.19. Australia Molecular Imaging Market Analysis

        21.19.1. By Modality

        21.19.2. By Application

        21.19.3. By End User

    21.20. New Zealand Molecular Imaging Market Analysis

        21.20.1. By Modality

        21.20.2. By Application

        21.20.3. By End User

    21.21. GCC Countries Molecular Imaging Market Analysis

        21.21.1. By Modality

        21.21.2. By Application

        21.21.3. By End User

    21.22. South Africa Molecular Imaging Market Analysis

        21.22.1. By Modality

        21.22.2. By Application

        21.22.3. By End User

22. Market Structure Analysis

    22.1. Market Analysis by Tier of Companies

    22.2. Market Share Analysis of Top Players

    22.3. Competition Intensity Mapping By Market Taxonomy

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Benchmarking

    23.3. Competition Deep Dive 

        23.3.1. GE Company

            23.3.1.1. Overview

            23.3.1.2. Product Portfolio

            23.3.1.3. Financial Overview

            23.3.1.4. Strategy Overview

            23.3.1.5. SWOT

            23.3.1.6. Key Developments

        23.3.2. Fujifilm Holdings Corporation

            23.3.2.1. Overview

            23.3.2.2. Product Portfolio

            23.3.2.3. Financial Overview

            23.3.2.4. Strategy Overview

            23.3.2.5. SWOT

            23.3.2.6. Key Developments

        23.3.3. Siemens AG

            23.3.3.1. Overview

            23.3.3.2. Product Portfolio

            23.3.3.3. Financial Overview

            23.3.3.4. Strategy Overview

            23.3.3.5. SWOT

            23.3.3.6. Key Developments

        23.3.4. Koninklijke Philips N.V.

            23.3.4.1. Overview

            23.3.4.2. Product Portfolio

            23.3.4.3. Financial Overview

            23.3.4.4. Strategy Overview

            23.3.4.5. SWOT

            23.3.4.6. Key Developments

        23.3.5. Toshiba Medical System Corp.

            23.3.5.1. Overview

            23.3.5.2. Product Portfolio

            23.3.5.3. Financial Overview

            23.3.5.4. Strategy Overview

            23.3.5.5. SWOT

            23.3.5.6. Key Developments

        23.3.6. Hitachi Medical Corp.

            23.3.6.1. Overview

            23.3.6.2. Product Portfolio

            23.3.6.3. Financial Overview

            23.3.6.4. Strategy Overview

            23.3.6.5. SWOT

            23.3.6.6. Key Developments

        23.3.7. Medisco Ltd.

            23.3.7.1. Overview

            23.3.7.2. Product Portfolio

            23.3.7.3. Financial Overview

            23.3.7.4. Strategy Overview

            23.3.7.5. SWOT

            23.3.7.6. Key Developments

        23.3.8. Positrion Corporation

            23.3.8.1. Overview

            23.3.8.2. Product Portfolio

            23.3.8.3. Financial Overview

            23.3.8.4. Strategy Overview

            23.3.8.5. SWOT

            23.3.8.6. Key Developments

        23.3.9. Esaote SpA

            23.3.9.1. Overview

            23.3.9.2. Product Portfolio

            23.3.9.3. Financial Overview

            23.3.9.4. Strategy Overview

            23.3.9.5. SWOT

            23.3.9.6. Key Developments

        23.3.10. Carestream Health Inc.

            23.3.10.1. Overview

            23.3.10.2. Product Portfolio

            23.3.10.3. Financial Overview

            23.3.10.4. Strategy Overview

            23.3.10.5. SWOT

            23.3.10.6. Key Developments

        23.3.11. Mirada Medical Limited

            23.3.11.1. Overview

            23.3.11.2. Product Portfolio

            23.3.11.3. Financial Overview

            23.3.11.4. Strategy Overview

            23.3.11.5. SWOT

            23.3.11.6. Key Developments

        23.3.12. MIM Software Inc.

            23.3.12.1. Overview

            23.3.12.2. Product Portfolio

            23.3.12.3. Financial Overview

            23.3.12.4. Strategy Overview

            23.3.12.5. SWOT

            23.3.12.6. Key Developments

        23.3.13. Bruker Corporation

            23.3.13.1. Overview

            23.3.13.2. Product Portfolio

            23.3.13.3. Financial Overview

            23.3.13.4. Strategy Overview

            23.3.13.5. SWOT

            23.3.13.6. Key Developments

        23.3.14. Hermes Medical Solutions

            23.3.14.1. Overview

            23.3.14.2. Product Portfolio

            23.3.14.3. Financial Overview

            23.3.14.4. Strategy Overview

            23.3.14.5. SWOT

            23.3.14.6. Key Developments

24. Assumptions and Acronyms Used

25. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Molecular Imaging Market Demand (in Volume 000'Units) Analysis- and Opportunity Assessment 2016–2031, By Modality

Table 02: Global Molecular Imaging Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By Modality

Table 03: Global Molecular Imaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application

Table 04: Global Molecular Imaging Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016–2031, By End User

Table 05: Global Molecular Imaging Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Region

Table 06: North America Molecular Imaging Market Demand (in Volume 000'Units) Analysis 2016-2020 and Forecast 2021–2031, By Modality

Table 07: North America Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Modality

Table 08: North America Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Application

Table 09: North America Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By End User

Table 10: North America Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 11: Latin America Molecular Imaging Market Demand (in Volume 000'Units) Analysis 2016-2020 and Forecast 2021–2031, By Modality

Table 12: Latin America Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Modality

Table 13: Latin America Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Application

Table 14: Latin America Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By End User

Table 15: Latin America Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 16: Europe Molecular Imaging Market Demand (in Volume 000'Units) Analysis 2016-2020 and Forecast 2021–2031, By Modality

Table 17: Europe Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Modality

Table 18: Europe Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Application

Table 19: Europe Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By End User

Table 20: Europe Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 21: South Asia Molecular Imaging Market Demand (in Volume 000'Units) Analysis 2016-2020 and Forecast 2021–2031, By Modality

Table 22: South Asia Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Modality

Table 23: South Asia Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Application

Table 24: South Asia Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By End User

Table 25: South Asia Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 26: East Asia Molecular Imaging Market Demand (in Volume 000'Units) Analysis 2016-2020 and Forecast 2021–2031, By Modality

Table 27: East Asia Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Modality

Table 28: East Asia Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Application

Table 29: East Asia Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By End User

Table 30: East Asia Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 31: Oceania Molecular Imaging Market Demand (in Volume 000'Units) Analysis 2016-2020 and Forecast 2021–2031, By Modality

Table 32: Oceania Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Modality

Table 33: Oceania Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Application

Table 34: Oceania Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By End User

Table 35: Oceania Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 36: Middle East and Africa Molecular Imaging Market Demand (in Volume 000'Units) Analysis 2016-2020 and Forecast 2021–2031, By Modality

Table 37: Middle East and Africa Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Modality

Table 38: Middle East and Africa Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Application

Table 39: Middle East and Africa Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By End User

Table 40: Middle East and Africa Molecular Imaging Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Molecular Imaging Market Historical Market Volume Analysis, 2016-2020

Figure 1: Country Average Pricing Analysis Benchmark USD/ Per Unit (2020)

Figure 02: Global Molecular Imaging Current and Future Market Volume, 2021-2031 & Y-o-Y Growth Trend Analysis

Figure 03: Global Molecular Imaging Market Value Analysis (US$ Mn), 2016-2020

Figure 04: Global Molecular Imaging Market Value Forecast (US$ Mn), 2021-2031 & Y-o-Y Growth (%), 2021-2031

Figure 05: Global Molecular Imaging Market Absolute $ Opportunity, 2021-2031

Figure 06: Global Molecular Imaging Market Share Analysis (%), By Modality, 2020 & 2031

Figure 07: Global Molecular Imaging Market Y-o-Y Analysis (%), By Modality, 2021-2031

Figure 08: Global Molecular Imaging Market Attractiveness Analysis by Modality, 2021-2031 

Figure 09: Global Molecular Imaging Market Share Analysis (%), By Application, 2020 & 2031

Figure 10: Global Molecular Imaging Market Y-o-Y Analysis (%), By Application, 2021-2031

Figure 11: Global Molecular Imaging Market Attractiveness Analysis by Application, 2021-2031 

Figure 12: Global Molecular Imaging Market Share Analysis (%), By End User, 2020 & 2031

Figure 13: Global Molecular Imaging Market Y-o-Y Analysis (%), By End User, 2021-2031

Figure 14: Global Molecular Imaging Market Attractiveness Analysis by End User, 2021-2031 

Figure 15: Global Molecular Imaging Market Share Analysis (%), By Region, 2020 & 2031

Figure 16: Global Molecular Imaging Market Y-o-Y Analysis (%), By Region, 2021-2031

Figure 17: Global Molecular Imaging Market Attractiveness Analysis by Region, 2021-2031

Figure 18: North America Molecular Imaging Market Value Analysis (US$ Mn), 2016-2020

Figure 19: North America Molecular Imaging Market Value Forecast (US$ Mn), 2021-2031 & Y-o-Y Growth (%), 2021-2031

Figure 20: North America Molecular Imaging Market Share, By Modality (2021)

Figure 21: North America Molecular Imaging Market Share, By End User (2021)

Figure 22: North America Molecular Imaging Market Share, By Application (2021)

Figure 23: North America Molecular Imaging Market Share, By Country (2021)

Figure 24: North America Molecular Imaging Market Attractiveness Analysis by Modality, 2021-2031

Figure 25: North America Molecular Imaging Market Attractiveness Analysis by Application, 2021-2031

Figure 26: North America Molecular Imaging Market Attractiveness Analysis by End User, 2021-2031

Figure 27: North America Molecular Imaging Market Attractiveness Analysis by Country, 2021-2031

Figure 28: Latin America Molecular Imaging Market Value Analysis (US$ Mn), 2016-2020

Figure 29: Latin America Molecular Imaging Market Value Forecast (US$ Mn), 2021-2031 & Y-o-Y Growth (%), 2021-2031

Figure 30: Latin America Molecular Imaging Market Share, By Modality (2020)

Figure 31: Latin America Molecular Imaging Market Share, By End User (2020)

Figure 32: Latin America Molecular Imaging Market Share, By Application (2020)

Figure 33: Latin America Molecular Imaging Market Share, By Country (2020)

Figure 34: Latin America Molecular Imaging Market Attractiveness Analysis by Modality, 2021-2031 

Figure 35: Latin America Molecular Imaging Market Attractiveness Analysis by Application, 2021-2031

Figure 36: Latin America Molecular Imaging Market Attractiveness Analysis by End User, 2021-2031 

Figure 37: Latin America Molecular Imaging Market Attractiveness Analysis by Country, 2021-2031 

Figure 38: Europe Molecular Imaging Market Value Analysis (US$ Mn), 2016-2020

Figure 39: Europe Molecular Imaging Market Value Forecast (US$ Mn), 2021-2031 & Y-o-Y Growth (%), 2021-2031

Figure 40: Europe Molecular Imaging Market Share, By Modality (2020)

Figure 41: Europe Molecular Imaging Market Share, By End User (2020)

Figure 42: Europe Molecular Imaging Market Share, By Application (2020)

Figure 43: Europe Molecular Imaging Market Share, By Country (2020)

Figure 44: Europe Molecular Imaging Market Attractiveness Analysis by Modality, 2021-2031 

Figure 45: Europe Molecular Imaging Market Attractiveness Analysis by Application, 2021-2031

Figure 46: Europe Molecular Imaging Market Attractiveness Analysis by End User, 2021-2031 

Figure 47: Europe Molecular Imaging Market Attractiveness Analysis by Country, 2021-2031 

Figure 48: South Asia Molecular Imaging Market Value Analysis (US$ Mn), 2016-2020

Figure 49: South Asia Molecular Imaging Market Value Forecast (US$ Mn), 2021-2031 & Y-o-Y Growth (%), 2021-2031

Figure 50: South Asia Molecular Imaging Market Share, By Modality (2020)

Figure 51: South Asia Molecular Imaging Market Share, By End User (2020)

Figure 52: South Asia Molecular Imaging Market Share, By Application (2020)

Figure 53: South Asia Molecular Imaging Market Share, By Country (2020)

Figure 54: South Asia Molecular Imaging Market Attractiveness Analysis by Modality, 2021-2031 

Figure 55: South Asia Molecular Imaging Market Attractiveness Analysis by Application, 2021-2031

Figure 56: South Asia Molecular Imaging Market Attractiveness Analysis by End User, 2021-2031 

Figure 57: South Asia Molecular Imaging Market Attractiveness Analysis by Country, 2021-2031 

Figure 58: East Asia Molecular Imaging Market Value Analysis (US$ Mn), 2016-2020

Figure 59: East Asia Molecular Imaging Market Value Forecast (US$ Mn), 2021-2031 & Y-o-Y Growth (%), 2021-2031

Figure 60: East Asia Molecular Imaging Market Share, By Modality (2020)

Figure 61: East Asia Molecular Imaging Market Share, By End User (2020)

Figure 62: East Asia Molecular Imaging Market Share, By Application (2020)

Figure 63: East Asia Molecular Imaging Market Share, By Country (2020)

Figure 64: East Asia Molecular Imaging Market Attractiveness Analysis by Modality, 2021-2031 

Figure 65: East Asia Molecular Imaging Market Attractiveness Analysis by Application, 2021-2031

Figure 66: East Asia Molecular Imaging Market Attractiveness Analysis by End User, 2021-2031 

Figure 67: East Asia Molecular Imaging Market Attractiveness Analysis by Country, 2021-2031 

Figure 68: Oceania Molecular Imaging Market Value Analysis (US$ Mn), 2016-2020

Figure 69: Oceania Molecular Imaging Market Value Forecast (US$ Mn), 2021-2031 & Y-o-Y Growth (%), 2021-2031

Figure 70: Oceania Molecular Imaging Market Share, By Modality (2020)

Figure 71: Oceania Molecular Imaging Market Share, By End User (2020)

Figure 72: Oceania Molecular Imaging Market Share, By Application (2020)

Figure 73: Oceania Molecular Imaging Market Share, By Country (2020)

Figure 74: Oceania Molecular Imaging Market Attractiveness Analysis by Modality, 2021-2031 

Figure 75: Oceania Molecular Imaging Market Attractiveness Analysis by Application, 2021-2031

Figure 76: Oceania Molecular Imaging Market Attractiveness Analysis by End User, 2021-2031 

Figure 77: Oceania Molecular Imaging Market Attractiveness Analysis by Country, 2021-2031 

Figure 78: Middle East and Africa Molecular Imaging Market Value Analysis (US$ Mn), 2016-2020

Figure 79: Middle East and Africa Molecular Imaging Market Value Forecast (US$ Mn), 2021-2031 & Y-o-Y Growth (%), 2021-2031

Figure 80: Middle East and Africa Molecular Imaging Market Share, By Modality (2020)

Figure 81: Middle East and Africa Molecular Imaging Market Share, By End User (2020)

Figure 82: Middle East and Africa Molecular Imaging Market Share, By Application (2020)

Figure 83: Middle East and Africa Molecular Imaging Market Share, By Country (2020)

Figure 84: Middle East and Africa Molecular Imaging Market Attractiveness Analysis by Modality, 2021-2031 

Figure 85: Middle East and Africa Molecular Imaging Market Attractiveness Analysis by Application, 2021-2031

Figure 86: Middle East and Africa Molecular Imaging Market Attractiveness Analysis by End User, 2021-2031 

Figure 87: Middle East and Africa Molecular Imaging Market Attractiveness Analysis by Country, 2021-2031 

Figure 88: U.S Market Value Proportion Analysis, 2020

Figure 89: Global Vs. U.S Growth Comparison

Figure 90: U.S. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 91: U.S. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 92: U.S. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 93: Canada Market Value Proportion Analysis, 2020

Figure 94: Global Vs. Canada Growth Comparison

Figure 95: Canada. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 96: Canada. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 97: Canada. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 98: Mexico Market Value Proportion Analysis, 2020

Figure 99: Global Vs. Mexico Growth Comparison

Figure 100: Mexico. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 101: Mexico. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 102: Mexico. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 103: Brazil Market Value Proportion Analysis, 2020

Figure 104: Global Vs. Brazil Growth Comparison

Figure 105: Brazil. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 106: Brazil. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 107: Brazil. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 108: U.K. Market Value Proportion Analysis, 2020

Figure 109: Global Vs. U.K. Growth Comparison

Figure 110: U.K. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 111: U.K. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 112: U.K. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 113: Germany Market Value Proportion Analysis, 2020

Figure 114: Global Vs. Germany Growth Comparison

Figure 115: Germany. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 116: Germany. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 117: Germany. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 118: France Market Value Proportion Analysis, 2020

Figure 119: Global Vs. France Growth Comparison

Figure 120: France. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 121: France. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 122: France. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 123: Italy Market Value Proportion Analysis, 2020

Figure 124: Global Vs. Italy Growth Comparison

Figure 125: Italy. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 126: Italy. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 127: Italy. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 128: Spain Market Value Proportion Analysis, 2020

Figure 129: Global Vs. Spain Growth Comparison

Figure 130: Spain. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 131: Spain. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 132: Spain. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 133: Russia Market Value Proportion Analysis, 2020

Figure 134: Global Vs. Russia Growth Comparison

Figure 135: Russia. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 136: Russia. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 137: Russia. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 138: BENELUX Market Value Proportion Analysis, 2020

Figure 139: Global Vs. BENELUX Growth Comparison

Figure 140: BENELUX. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 141: BENELUX. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 142: BENELUX. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 143: Poland Market Value Proportion Analysis, 2020

Figure 144: Global Vs. Poland Growth Comparison

Figure 145: Poland. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 146: Poland. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 147: Poland. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 148: China Market Value Proportion Analysis, 2020

Figure 149: Global Vs. China Growth Comparison

Figure 150: China. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 151: China. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 152: China. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 153: Japan Market Value Proportion Analysis, 2020

Figure 154: Global Vs. Japan Growth Comparison

Figure 155: Japan. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 156: Japan. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 157: Japan. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 158: South Korea Market Value Proportion Analysis, 2020

Figure 159: Global Vs. South Korea Growth Comparison

Figure 160: South Korea. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 161: South Korea. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 162: South Korea. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 163: India Market Value Proportion Analysis, 2020

Figure 164: Global Vs. India Growth Comparison

Figure 165: India. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 166: India. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 167: India. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 168: ASEAN Market Value Proportion Analysis, 2020

Figure 169: Global Vs. ASEAN Growth Comparison

Figure 170: ASEAN. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 171: ASEAN. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 172: ASEAN. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 173: Australia Market Value Proportion Analysis, 2020

Figure 174: Global Vs. Australia Growth Comparison

Figure 175: Australia. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 176: Australia. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 177: Australia. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 178: New Zealand Market Value Proportion Analysis, 2020

Figure 179: Global Vs. New Zealand Growth Comparison

Figure 180: New Zealand. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 181: New Zealand. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 182: New Zealand. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 183: GCC Countries Market Value Proportion Analysis, 2020

Figure 184: Global Vs. GCC Countries Growth Comparison

Figure 185: GCC Countries. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 186: GCC Countries. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 187: GCC Countries. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Figure 188: South Africa Market Value Proportion Analysis, 2020

Figure 189: Global Vs. South Africa Growth Comparison

Figure 190: South Africa. Molecular Imaging Market Share Analysis (%) By Modality, 2020 & 2031

Figure 191: South Africa. Molecular Imaging Market Share Analysis (%) By Application, 2020 & 2031

Figure 192: South Africa. Molecular Imaging Market Share Analysis (%) By End User, 2020 & 2031

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Perfusion Imaging Market

Published : June 2019

Healthcare

Chemiluminescence Imaging Market

Published : April 2017

Healthcare

Preclinical Imaging Market

Published : January 2017

Healthcare

Optical Imaging Market

Published : January 1970

Google translate

Molecular Imaging Market